13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 4 managers

Reported value

$41.2M

Holders

4

+1 new · −1 exited

Holders’ est. mark

−$2.15M

Price effect on 3 books still in the name

Largest holder

$28.7M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC162.2K$28.7M−$2.08MCut−$11.2M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main12.5M$11.6MNew
Swiss Life Asset Management Ltd4.19K$741K−$55.1KCut−$79.6K
Leonteq Securities AG583$103.2K−$7.49KCut−$31.8K

Who left

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.